Performance of an automated insulin‐glucagon delivery system versus automated insulin delivery system during challenging inpatient conditions. A single‐blind randomised controlled crossover trial
Diabetes, Obesity and Metabolism · 2026
DOI: 10.1111/dom.70577 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Diabetes, Obesity and Metabolism, 2026. Verfasst von Ajenthen G Ranjan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Diabetes Technology Research, Clinical and Translational Research, Steno Diabetes Center Copenhagen, Herlev, Denmark. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Glucagon, Hypoglycemic Agents, Insulin. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Danish Diabetes and Endocrine Academy.
Abstract (Originalsprache)
Aims To assess the efficacy and safety of an automated insulin‐glucagon delivery system (AIGD) compared with an automated insulin delivery system (AID). Materials and methods In a 33‐h, randomised, crossover, inpatient study, 13 participants with type 1 diabetes used the DiaCon system in AIGD and AID modes. Each study period included two overnight stays and standardised challenges: receiving 50% of the calculated insulin bolus for breakfast, 100% bolus for lunch, 130% bolus for dinner, and a 45‐min unannounced bicycle exercise at 50% VO 2max . Co‐primary endpoints were (1) number of 15‐g carbohydrate treatments for plasma glucose 10.0 mmol/L (27.5 ± 14.8% vs. 29.2 ± 10.4%, p = 0.46) were similar. Mean glucose and coefficient of variation were comparable between AIGD versus AID ( p = 0.30). The post hoc analysis demonstrated that AIGD had significantly higher TIR 0–3 h after exercise and fewer hypoglycaemia events (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Diabetes Technology Research, Clinical and Translational Research, Steno Diabetes Center Copenhagen, Herlev, Denmark.
- Danish Diabetes Academy, Odense, Denmark.
- Department of Applied Mathematics and Computer Science, Technical University of Denmark, Kongens Lyngby, Denmark.
- Novo Nordisk Foundation Center for Basic Metabolic Research and Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
- Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
ORCID-Profile: Ajenthen G Ranjan, Christian Laugesen, Signe Schmidt, Jens Juul Holst
Förderung
- Danish Diabetes and Endocrine Academy
Zitieren
APA
Ranjan, A. G., Laugesen, C., Boiroux, D., Schmidt, S., Reenberg, A. T., Holst, J. J., Jørgensen, J. B., & Nørgaard, K. (2026). Performance of an automated insulin‐glucagon delivery system versus automated insulin delivery system during challenging inpatient conditions. A single‐blind randomised controlled crossover trial. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.70577
Vancouver
Ranjan AG, Laugesen C, Boiroux D, Schmidt S, Reenberg AT, Holst JJ, et al. Performance of an automated insulin‐glucagon delivery system versus automated insulin delivery system during challenging inpatient conditions. A single‐blind randomised controlled crossover trial. Diabetes, Obesity and Metabolism. 2026. doi:10.1111/dom.70577
BibTeX
@article{Ranjan2026,
author = {Ranjan, Ajenthen G and Laugesen, Christian and Boiroux, Dimitri and Schmidt, Signe and Reenberg, Asbjørn T and Holst, Jens Juul and Jørgensen, John B and Nørgaard, Kirsten},
title = {Performance of an automated insulin‐glucagon delivery system versus automated insulin delivery system during challenging inpatient conditions. A single‐blind randomised controlled crossover trial},
journal = {Diabetes, Obesity and Metabolism},
year = {2026},
doi = {10.1111/dom.70577}
}
EUVIMED